Opinion
The Malaysian ReserveOpinion

UCB Canada remains dedicated to helping patients and working collaboratively with CDA-AMC following draft recommendation for (Pr)BIMZELX® for hidradenitis suppurativa (HS)

Canadians living with HS at risk of inequitable access to newly approved therapy, falling behind Australia, France, Germany, Scotland and other ...